Squarepoint’s Hologic HOLX Stock Holding History

Squarepoint’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-99,500	Closed	-$7.76M	–	4309
2024 Q1	$7.76M	Buy	+99,500	New	+$7.4M	0.01%	1154
2023 Q2	–	Sell	-22,700	Closed	-$1.83M	–	3742
2023 Q1	$1.83M	Sell	22,700 -1,700	-7%	-$137K	0.01%	1479
2022 Q4	$1.83M	Buy	+24,400	New	+$1.74M	0.01%	1426

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Squarepoint's HOLX Position: Q2 2026 in Review

Squarepoint sold out of Hologic (HOLX) in Q2 2026, closing a stake of 1,152,092 shares — an estimated $87.1M sold.

Squarepoint first reported a position in HOLX in Q4 2015 and held it in 32 quarters. The position peaked at $87.1M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

Squarepoint reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
Squarepoint sold 1,152,092 Hologic shares in Q2 2026, an estimated $87.1M.
Squarepoint first reported a position in Hologic in Q4 2015 and held it in 32 quarters.
Squarepoint's Hologic position peaked at $87.1M in Q1 2026.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.